000 04476cam a2200565Ia 4500
001 ocn228148277
003 OCoLC
005 20141103172212.0
006 m o d
007 cr cn|||||||||
008 080516s2007 enkaf ob 001 0 eng d
040 _aOPELS
_beng
_cOPELS
_dOCLCQ
_dOCLCF
_dCHVBK
020 _a9780123694485
020 _a0123694485
029 1 _aNZ1
_b12541708
029 1 _aDKDLA
_b820120-katalog:000577709
029 1 _aDEBSZ
_b405318618
029 1 _aCHVBK
_b122271564
029 1 _aCHDSB
_b005985912
035 _a(OCoLC)228148277
037 _a114525:114618
_bElsevier Science & Technology
_nhttp://www.sciencedirect.com
050 4 _aRS431.A64
_bC36 2008eb
060 4 _a2008 A-287
060 4 _aQV 269
_bN397c 2008
082 0 4 _a616.994061
_222
049 _aTEFA
245 0 0 _aCancer drug design and discovery
_h[electronic resource] /
_cedited by Stephen Neidle.
250 _a1st ed.
260 _aNew York, NY :
_bAcademic Press,
_c2008.
300 _a1 online resource (xv, 473 p., [27] p. of plates) :
_bill. (some col.)
520 _aThe ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories.
505 0 _aSection I. Basic Principles -- 1. Modern cancer drug discovery: Integrating targets, technologies and treatments -- 2. Preclinical pharmacology and in vivo models -- 3. Clinical trial designs for more rapid proof-of-principle and approval -- Section II. Methodology -- 4. Structural biology and anticancer drug design -- 5. Natural product chemistry and cancer drug discovery -- 6. Pharmacokinetics & ADME optimization in drug discovery -- Section III. Drugs in the clinic and laboratory -- 7. Temozolomide: from cytotoxic to molecularly-targeted agent -- 8. Camptothecins for drug design, cancer cell death and gene targeting -- 9. Targeting thymidylate synthase by antifolate drugs for the treatment of cancer -- Section IV. New Agents -- 10. Targeting inactive kinases: structure as a foundation for cancer drug discovery -- 11. Cell cycle inhibitors in cancer: current status and future directions -- 12. Inhibition of DNA repair as a therapeutic target -- 13. Heat shock protein-90 inhibitors: targeting the cancer chaperone for combinatorial blockade of oncogenic pathways -- 14. Heat shock protein-90-directed therapeutics and target validation -- 15. Inhibitors of tumour angiogenesis -- 16. The biology and oncology of RAFERK signalling P53 as a therapeutic target -- Section V. The reality of cancer drugs in the clinic -- 17. Cancer drug resistance -- 18. Failure Modes in Anticancer Drug Discovery and Development.
504 _aIncludes bibliographical references and index.
588 _aDescription based on print version record.
650 0 _aAntineoplastic agents
_xDevelopment.
650 0 _aAntineoplastic agents
_xDesign.
650 0 _aCancer
_xChemotherapy.
650 7 _aAntineoplastic agents
_xDesign.
_2fast
_0(OCoLC)fst00810598
650 7 _aAntineoplastic agents
_xDevelopment.
_2fast
_0(OCoLC)fst00810599
650 7 _aCancer
_xChemotherapy.
_2fast
_0(OCoLC)fst00845327
650 2 _aAntineoplastic Agents.
650 2 _aDrug Design.
650 2 _aNeoplasms
_xdrug therapy.
655 4 _aElectronic books.
700 1 _aNeidle, Stephen.
776 0 8 _iPrint version:
_tCancer drug design and discovery.
_b1st ed.
_dNew York, NY : Academic Press, 2008
_z9780123694485
_z0123694485
_w(OCoLC)154760280
856 4 0 _3ScienceDirect
_uhttp://www.sciencedirect.com/science/book/9780123694485
942 _cEB
994 _aC0
_bTEF
999 _c20999
_d20999